Cardio Diagnostics Holdings (CDIO) is trading at $2.05 (up 1.2%) today. The modest gain follows yesterday's announcement of a significant partnership with Atlas Healthcare Physicians. - The collaboration will allow Atlas Healthcare Physicians members to access CDIO's Epi+Gen CHD and PrecisionCHD diagnostic tests, expanding patient access to advanced cardiovascular assessments. - This partnership is considered a pivotal moment for the small-cap biotechnology company, aiming to improve management of coronary heart disease.